• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-203通过靶向细胞因子信号转导抑制因子3调控卵巢癌细胞的增殖和凋亡。

MiR-203 regulates proliferation and apoptosis of ovarian cancer cells by targeting SOCS3.

作者信息

Liu H-P, Zhang Y, Liu Z-T, Qi H, Zheng X-M, Qi L-H, Wang J-Y

机构信息

Department of Reproductive Medicine Center, The 960th Hospital of the PLA Joint Logistics Support Force, Jinan, Shandong, China.

出版信息

Eur Rev Med Pharmacol Sci. 2020 Aug;24(15):7914. doi: 10.26355/eurrev_202008_22448.

DOI:10.26355/eurrev_202008_22448
PMID:32767307
Abstract

Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "MiR-203 regulates proliferation and apoptosis of ovarian cancer cells by targeting SOCS3, by H.-P. Liu, Y. Zhang, Z.-T. Liu, H. Qi, X.-M. Zheng, L.-H. Qi, J.-Y. Wang, published in Eur Rev Med Pharmacol Sci 2019; 23 (21): 9286-9294-DOI: 10.26355/eurrev_201911_19421-PMID: 31773696" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/19421.

摘要

由于本文被怀疑存在研究不当行为,且通讯作者未回应我们要求证明数据和图表原创性的请求,因此“H.-P. Liu、Y. Zhang、Z.-T. Liu、H. Qi、X.-M. Zheng、L.-H. Qi、J.-Y. Wang发表于《欧洲医学与药理学评论》2019年;23(21):9286 - 9294 - DOI: 10.26355/eurrev_201911_19421 - PMID: 31773696”的文章已被撤回。出版商对由此可能造成的任何不便表示歉意。https://www.europeanreview.org/article/19421 。

相似文献

1
MiR-203 regulates proliferation and apoptosis of ovarian cancer cells by targeting SOCS3.微小RNA-203通过靶向细胞因子信号转导抑制因子3调控卵巢癌细胞的增殖和凋亡。
Eur Rev Med Pharmacol Sci. 2020 Aug;24(15):7914. doi: 10.26355/eurrev_202008_22448.
2
MiR-155 regulates the proliferation and apoptosis of pancreatic cancer cells through targeting SOCS3.微小RNA-155通过靶向细胞因子信号转导抑制因子3调控胰腺癌细胞的增殖和凋亡。
Eur Rev Med Pharmacol Sci. 2020 Dec;24(24):12625. doi: 10.26355/eurrev_202012_24143.
3
MiR-221 affects proliferation and apoptosis of gastric cancer cells through targeting SOCS3.微小RNA-221通过靶向细胞因子信号转导抑制因子3影响胃癌细胞的增殖和凋亡。
Eur Rev Med Pharmacol Sci. 2020 Jul;24(14):7565. doi: 10.26355/eurrev_202007_22226.
4
MiR-155 regulates lymphoma cell proliferation and apoptosis through targeting SOCS3/JAK-STAT3 signaling pathway.微小RNA-155通过靶向细胞因子信号转导抑制因子3/Janus激酶-信号转导子和转录激活子3信号通路调控淋巴瘤细胞的增殖和凋亡。
Eur Rev Med Pharmacol Sci. 2020 Jul;24(14):7577. doi: 10.26355/eurrev_202007_22251.
5
Long noncoding RNA PCAT-1 promoted ovarian cancer cell proliferation and invasion by suppressing KLF6.长链非编码RNA PCAT-1通过抑制KLF6促进卵巢癌细胞的增殖和侵袭。
Eur Rev Med Pharmacol Sci. 2020 Jul;24(14):7566. doi: 10.26355/eurrev_202007_22228.
6
MiR-532-5p acts as a tumor suppressor and inhibits glioma cell proliferation by targeting CSF1.微小RNA-532-5p作为一种肿瘤抑制因子,通过靶向集落刺激因子1来抑制胶质瘤细胞的增殖。
Eur Rev Med Pharmacol Sci. 2020 Jul;24(13):7206. doi: 10.26355/eurrev_202007_21856.
7
MiR-410 affects the proliferation and apoptosis of lung cancer A549 cells through regulation of SOCS3/JAK-STAT signaling pathway.微小RNA-410通过调控细胞因子信号转导抑制因子3/Janus激酶-信号转导子和转录激活子信号通路影响肺癌A549细胞的增殖和凋亡。
Eur Rev Med Pharmacol Sci. 2020 Nov;24(22):11462. doi: 10.26355/eurrev_202011_23747.
8
Long noncoding RNA SNHG14 acts as an oncogene in prostate cancer via targeting miR-613.长链非编码RNA SNHG14通过靶向miR-613在前列腺癌中发挥癌基因作用。
Eur Rev Med Pharmacol Sci. 2020 Nov;24(21):10919. doi: 10.26355/eurrev_202011_23556.
9
Long noncoding RNA ZFPM2-AS1 promotes the tumorigenesis of renal cell cancer via targeting miR-137.长链非编码RNA ZFPM2-AS1通过靶向miR-137促进肾细胞癌的肿瘤发生。
Eur Rev Med Pharmacol Sci. 2020 Sep;24(18):9238. doi: 10.26355/eurrev_202009_22996.
10
MiR-218 promotes apoptosis of U2OS osteosarcoma cells through targeting BIRC5.微小RNA-218通过靶向BIRC5促进U2OS骨肉瘤细胞凋亡。
Eur Rev Med Pharmacol Sci. 2020 Aug;24(16):8242. doi: 10.26355/eurrev_202008_22582.

引用本文的文献

1
Exosomal miR-203 from bone marrow stem cells targets the SOCS3/NF-κB pathway to regulate neuroinflammation in temporal lobe epilepsy.来自骨髓干细胞的外泌体miR-203靶向SOCS3/NF-κB通路以调节颞叶癫痫中的神经炎症。
World J Stem Cells. 2025 Feb 26;17(2):101395. doi: 10.4252/wjsc.v17.i2.101395.
2
CircTHSD4 promotes the malignancy and docetaxel (DTX) resistance in prostate cancer by regulating miR-203/HMGA2 axis.环状 THSD4 通过调控 miR-203/HMGA2 轴促进前列腺癌的恶性转化和多西他赛(DTX)耐药性。
Oncol Res. 2024 Feb 6;32(3):529-544. doi: 10.32604/or.2023.031511. eCollection 2024.
3
MicroRNAs Regulate Tumorigenesis by Downregulating SOCS3 Expression: An Approach.
微小RNA通过下调SOCS3表达调控肿瘤发生:一种方法
Bioinform Biol Insights. 2023 Sep 9;17:11779322231193535. doi: 10.1177/11779322231193535. eCollection 2023.
4
Comprehensive miRNA and DNA Microarray Analyses Reveal the Response of Hepatic miR-203 and Its Target Gene to Protein Malnutrition in Rats.全面的 miRNA 和 DNA 微阵列分析揭示了大鼠肝脏 miR-203 及其靶基因对蛋白质营养不良的反应。
Genes (Basel). 2021 Dec 28;13(1):75. doi: 10.3390/genes13010075.